Windrose Medical Properties Trust's Underwriters Exercise Over-Allotment Option
08 Maio 2006 - 11:50AM
PR Newswire (US)
INDIANAPOLIS, May 8 /PRNewswire-FirstCall/ -- Windrose Medical
Properties Trust (NYSE:WRS), a self-managed specialty medical
properties REIT, announced today that the underwriters of the
Company's recent public offering have exercised the over-allotment
option to purchase 299,277 shares of common stock at the public
offering price of $14.80 per share. The closing of the
over-allotment option occurred on May 4, 2006. As a result of the
exercise, the Company received additional net proceeds, after
underwriting discounts and commissions, of approximately $4.2
million, which resulted in total net proceeds from the offering of
approximately $36.6 million. Robert W. Baird & Co. was
sole-book runner and Raymond James & Associates, Inc. was
co-manager. Copies of the prospectus supplement relating to the
offering may be obtained by contacting Robert W. Baird & Co.
Incorporated, 777 East Wisconsin Avenue, Milwaukee, WI 53201. This
press release shall not constitute an offer to sell or the
solicitation of an offer to buy nor shall there be any sale or an
offer to buy these securities in any state in which such offer,
solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such state. About
Windrose Windrose is a self-managed real estate investment trust
(REIT) based in Indianapolis, Indiana with offices in Nashville,
Tennessee. Windrose was formed to acquire, selectively develop and
manage specialty medical properties, such as medical office
buildings, ambulatory surgery centers, outpatient treatment and
diagnostic facilities, and specialty hospitals and treatment
centers. Safe Harbor Some of the statements in this news release,
including those related to this offering and use of proceeds,
constitute forward-looking statements. Such statements include, in
particular, statements about our beliefs, expectations, plans and
strategies that are not based on historical facts. You should not
rely on our forward-looking statements because the matters they
describe are subject to known and unknown risks, uncertainties,
assumptions and changes in circumstances, many of which are beyond
our control, which may cause our actual results to differ
significantly from those expressed in any forward- looking
statement. The factors that could cause actual results to differ
materially from current expectations include our ability to
complete this offering, our ability to deploy the net proceeds from
this offering, adverse changes in healthcare laws, changes in
economic and general business conditions, competition for specialty
medical properties, our ability to finance our operations,
regulatory conditions and other factors described from time to time
in filings we make with the Securities and Exchange Commission. The
forward-looking statements contained herein represent our judgment
as of the date hereof, and we caution readers not to place undue
reliance on such statements. We do not undertake to publicly update
or revise any forward- looking statement whether as a result of new
information, future events or otherwise. Contact: Investors/Media:
Windrose Medical Properties Trust The Ruth Group Fred Farrar
Stephanie Carrington/Jason Rando President and COO 646
536-7017/7025 317 860-8213 DATASOURCE: Windrose Medical Properties
Trust CONTACT: Fred Farrar, President and COO, Windrose Medical
Properties Trust, +1-317-860-8213; Investors, Media, Stephanie
Carrington, +1-646-536-7017, , or Jason Rando +1-646-536-7025, ,
both of The Ruth Group
Copyright
Windrose Medical (NYSE:WRS)
Gráfico Histórico do Ativo
De Ago 2024 até Set 2024
Windrose Medical (NYSE:WRS)
Gráfico Histórico do Ativo
De Set 2023 até Set 2024